Breaking News
Get 50% Off 0
Get a powerful boost to your portfolio: August's freshest AI-picked stocks
Pick Stocks with AI
Close

MiMedx Group Inc (MDXG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow MiMedx's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6.97 -0.18    -2.52%
05/08 - Closed. Currency in USD
After Hours
6.97
0.00
0.00%
21:20:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 906,079
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 6.97 - 7.20
MiMedx 6.97 -0.18 -2.52%

MiMedx Group Inc Company Profile

 
Get an in-depth profile of MiMedx Group Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

837

Equity Type

ORD

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company’s wound care products include EPIFIX, EPICORD, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company’s products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Contact Information

Address 1775 West Oak Commons Court, NE
Marietta, 30062
United States
Phone 770 651 9100
Fax -

Top Executives

Name Age Since Title
Thomas Zdeblick - - Member of Medical Advisory Board
James R. Andrews 82 - Member of Medical Advisory Board
Glenn Gaston - - Member of Medical Advisory Board
K. Todd Newton 62 2019 Independent Director
William A. Hawkins 71 2020 Independent Preferred Director
Robert E. Guldberg - - Member of Regenerative Medicine Scientific Advisory Board
Martin Paul Sutter 70 2020 Independent Preferred Director
James L. Bierman 72 2019 Independent Director
Joseph H. Capper 61 2023 CEO & Director
Constance Chu - 2022 Member of Regenerative Medicine Scientific Advisory Board
Philip G. Conaghan - 2022 Member of Regenerative Medicine Scientific Advisory Board
Eric W. Carson - 2022 Member of Regenerative Medicine Scientific Advisory Board
Regis J. O’Keefe - 2022 Member of Regenerative Medicine Scientific Advisory Board
Vibeke S. Strand - 2022 Member of Regenerative Medicine Scientific Advisory Board
Scott Rodeo - 2022 Member of Regenerative Medicine Scientific Advisory Board
Asger Bihlet - 2022 Member of Regenerative Medicine Scientific Advisory Board
Dorothy E. Puhy 73 2024 Independent Director
M. Kathleen Behrens Wilsey 73 - Independent Director
Cato T. Laurencin 66 2020 Independent Director
Kris John Alden - 2022 Member of Regenerative Medicine Scientific Advisory Board
Anthony Atala 67 2022 Member of Regenerative Medicine Scientific Advisory Board
Olga Kubassova - 2022 Member of Regenerative Medicine Scientific Advisory Board
Tiffany P. Olson 66 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MDXG Comments

Write your thoughts about MiMedx Group Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email